Evidence map›Paper›PMID 25422425›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity.

Lucy K Shewell, Richard M Harvey, Melanie A Higgins, Christopher J Day, Lauren E Hartley-Tassell, Austen Y Chen, Christine M Gillen, David B A James, Francis Alonzo, Victor J Torres and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Lucy K ShewellInstitute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia;
Richard M HarveyResearch Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia;
Melanie A HigginsResearch Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia;
Christopher J DayInstitute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia;
Lauren E Hartley-TassellInstitute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia;
Austen Y ChenResearch Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia;
Christine M GillenSchool of Chemistry and Molecular Biosciences and the Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia; and.
David B A JamesDepartment of Microbiology, New York University School of Medicine, New York, NY 10016.
Francis AlonzoDepartment of Microbiology, New York University School of Medicine, New York, NY 10016.
Victor J TorresDepartment of Microbiology, New York University School of Medicine, New York, NY 10016.
Mark J WalkerSchool of Chemistry and Molecular Biosciences and the Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia; and.
Adrienne W PatonResearch Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia;
James C PatonResearch Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia; james.paton@adelaide.edu.au m.jennings@griffith.edu.au.
Michael P JenningsInstitute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia; james.paton@adelaide.edu.au m.jennings@griffith.edu.au.
University of Adelaide · AUGriffith University · AUNew York University · USUniversity of Queensland · AU

Funding

INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
NIAID NIH HHS T32 AI007180NIAID NIH HHS T32AI007180
6 · The paper itself

Abstract

The cholesterol-dependent cytolysin (CDC) pneumolysin (Ply) is a key virulence factor of Streptococcus pneumoniae. Membrane cholesterol is required for the cytolytic activity of this toxin, but it is not clear whether cholesterol is the only cellular receptor. Analysis of Ply binding to a glycan microarray revealed that Ply has lectin activity and binds glycans, including the Lewis histo-blood group antigens. Surface plasmon resonance analysis showed that Ply has the highest affinity for the sialyl LewisX (sLeX) structure, with a K(d) of 1.88 × 10(-5) M. Ply hemolytic activity against human RBCs showed dose-dependent inhibition by sLeX. Flow cytometric analysis and Western blots showed that blocking binding of Ply to the sLeX glycolipid on RBCs prevents deposition of the toxin in the membrane. The lectin domain responsible for sLeX binding is in domain 4 of Ply, which contains candidate carbohydrate-binding sites. Mutagenesis of these predicted carbohydrate-binding residues of Ply resulted in a decrease in hemolytic activity and a reduced affinity for sLeX. This study reveals that this archetypal CDC requires interaction with the sLeX glycolipid cellular receptor as an essential step before membrane insertion. A similar analysis conducted on streptolysin O from Streptococcus pyogenes revealed that this CDC also has glycan-binding properties and that hemolytic activity against RBCs can be blocked with the glycan lacto-N-neotetraose by inhibiting binding to the cell surface. Together, these data support the emerging paradigm shift that pore-forming toxins, including CDCs, have cellular receptors other than cholesterol that define target cell tropism.

Indexed as

HemolysisAmino Acid SequenceBacterial ProteinsBinding SitesCarbohydratesCell Line, TumorCell MembraneErythrocytesFlow CytometryGlycolipidsHumansLewis X AntigenMolecular Sequence DataMutagenesisOligosaccharidesPolysaccharidesBacterial ProteinsCarbohydratesGlycolipidslacto-N-neotetraoseLewis X AntigenOligosaccharidesplY protein, Streptococcus pneumoniaePolysaccharidesstreptolysin OStreptolysinscholesterol-dependent cytolysinglycan bindingpneumolysinStreptococcus pneumoniaestreptolysin O

Identifiers

PMID25422425
PMCPMC4267402
OpenAlexW2080989088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.